◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › O › OMCL

Omnicell Inc (OMCL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-09-14

Omnicell Inc (OMCL) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in Fort Worth, United States with about 3,485 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, OMCL reported $1.2B in revenue and $2M in net income.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.

Interactive charts & full statements → Open the OMCL valuation workbench →

OMCL Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$1.2B	$1.2B	$1.1B	$1.1B	$1.3B	$1.1B	$892M	$897M	$787M	$716M	$693M	$485M	$441M	$381M	$314M	$246M	$222M	$213M	$252M	$213M	$155M
Gross Profit	$558M	$508M	$471M	$497M	$589M	$555M	$413M	$437M	$372M	$322M	$314M	$248M	$234M	$203M	$171M	$136M	$118M	$105M	$129M	$113M	$86M
Gross Margin %	44.8%	42.9%	42.4%	43.3%	45.5%	49.0%	46.3%	48.7%	47.3%	45.0%	45.3%	51.2%	53.0%	53.4%	54.3%	55.3%	53.0%	49.3%	51.1%	53.2%	55.3%
Operating Income (EBIT)	$59M	$12M	$0M	($35M)	($2M)	$90M	$36M	$78M	$44M	$6M	$6M	$49M	$50M	$35M	$27M	$16M	$10M	$1M	$17M	$18M	$9M
Operating Margin %	4.7%	1.0%	0.0%	-3.0%	-0.2%	7.9%	4.0%	8.7%	5.6%	0.8%	0.9%	10.0%	11.2%	9.3%	8.6%	6.6%	4.3%	0.3%	6.9%	8.6%	6.0%
Net Income	$39M	$2M	$13M	($20M)	$6M	$78M	$32M	$61M	$38M	$21M	$1M	$31M	$31M	$24M	$16M	$10M	$5M	$0M	$13M	$43M	$10M
Net Margin %	3.1%	0.2%	1.1%	-1.8%	0.4%	6.9%	3.6%	6.8%	4.8%	2.9%	0.1%	6.3%	6.9%	6.3%	5.1%	4.2%	2.2%	0.2%	5.1%	20.3%	6.7%
EBITDA	$106M	$102M	$120M	($35M)	$97M	$173M	$107M	$142M	$96M	$63M	$65M	$72M	$70M	$54M	$40M	$24M	$19M	$11M	$30M	$23M	$13M
Earnings Per Share (EPS)	$0.85	$0.04	$0.27	$-0.45	$0.12	$1.62	$0.74	$1.43	$0.93	$0.53	$0.02	$0.84	$0.83	$0.67	$0.47	$0.30	$0.15	$0.01	$0.38	$1.28	$0.36
Shares Outstanding (M)	46M	46M	46M	45M	46M	48M	44M	43M	41M	39M	37M	37M	37M	36M	34M	34M	34M	32M	33M	34M	29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMCL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$312M	$310M	$314M	$311M	$291M	$270M	$307M	$282M
Gross Profit	$153M	$140M	$130M	$135M	$128M	$111M	$143M	$123M
Gross Margin %	49.0%	45.3%	41.5%	43.3%	43.9%	41.1%	46.6%	43.5%
Operating Income (EBIT)	$32M	$17M	$1M	$8M	$8M	($12M)	$14M	$7M
Operating Margin %	10.4%	5.4%	0.4%	2.6%	2.8%	-4.3%	4.5%	2.5%
Net Income	$24M	$11M	($2M)	$5M	$6M	($7M)	$16M	$9M
Net Margin %	7.8%	3.7%	-0.7%	1.8%	1.9%	-2.6%	5.2%	3.1%
EBITDA	$14M	$35M	$25M	$31M	$32M	$13M	$47M	$34M
Earnings Per Share (EPS)	$0.53	$0.25	$-0.05	$0.12	$0.12	$-0.15	$0.34	$0.19
Shares Outstanding (M)	46M	46M	45M	46M	47M	47M	46M	46M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMCL Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$183M	$127M	$188M	$181M	$78M	$232M	$186M	$145M	$104M	$25M	$48M	$34M	$65M	$55M	$39M	$31M	$21M	$43M	$20M	$37M	$20M
Capital Expenditures (CapEx)	$41M	$40M	$36M	$41M	$61M	$29M	$55M	$62M	$54M	$31M	$29M	$20M	$23M	$20M	$21M	$13M	$7M	$4M	$12M	$7M	$4M
Free Cash Flow (FCF)	$141M	$87M	$151M	$140M	$17M	$203M	$131M	$83M	$50M	($6M)	$19M	$14M	$43M	$35M	$19M	$18M	$14M	$39M	$7M	$30M	$16M
FCF Margin %	11.3%	7.3%	13.6%	12.2%	1.3%	17.9%	14.7%	9.3%	6.3%	-0.8%	2.7%	2.8%	9.7%	9.2%	6.0%	7.4%	6.1%	18.4%	2.9%	14.2%	10.2%
Dividends Paid	—	—	—	$4M	—	—	$106M	$10M	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMCL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$70M	$54M	$30M	$28M	$43M	$26M	$56M	$23M
Capital Expenditures (CapEx)	$9M	$12M	$10M	$10M	$12M	$11M	$9M	$13M
Free Cash Flow (FCF)	$61M	$42M	$20M	$19M	$31M	$15M	$47M	$9M
FCF Margin %	19.4%	13.6%	6.4%	6.0%	10.7%	5.5%	15.4%	3.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMCL Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$2.0B	$2.0B	$2.1B	$2.2B	$2.2B	$2.1B	$1.8B	$1.2B	$1.1B	$980M	$935M	$579M	$560M	$493M	$444M	$362M	$343M	$321M	$309M	$328M	$155M
Cash & Cash Equivalents	$292M	$197M	$369M	$468M	$330M	$349M	$486M	$127M	$67M	$32M	$54M	$82M	$126M	$105M	$62M	$192M	$176M	$169M	$120M	$170M	$61M
Total Liabilities	$707M	$743M	$878M	$1.0B	$1.1B	$996M	$857M	$396M	$402M	$463M	$503M	$176M	$170M	$144M	$136M	$79M	$78M	$79M	$76M	$74M	$65M
Total Debt (Short + Long-Term)	$180M	$180M	$351M	$580M	$577M	$501M	$479M	$60M	$144M	$210M	$254M	$8M	$5M	$6M	$5M	$0M	$0M	$1M	$36M	$21M	$12M
Total Shareholders' Equity	$1.3B	$1.2B	$1.2B	$1.2B	$1.1B	$1.1B	$968M	$845M	$680M	$517M	$432M	$402M	$390M	$348M	$308M	$283M	$265M	$242M	$234M	$255M	$90M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OMCL viewer.

Other Companies in HEALTH INFORMATION SERVICES

DOCS · Doximity Inc — $5 billion
HTFL · Heartflow, Inc. Common Stock — $4 billion
PRVA · Privia Health Group Inc — $3 billion
SDGR · Schrodinger Inc — $2 billion
CERT · Certara Inc — $1 billion
OMDA · Omada Health, Inc. Common Stock — $1 billion
GDRX · Goodrx Holdings Inc — $1 billion
TDOC · Teladoc Inc — $1 billion

← OMC All “O” companies OMDA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.